Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and tissue penetration of amoxicillin/clavulanic acid in sepsis and septic shock
2016-002195-27Phase 4Completed
- Sponsor
- University of Tartu
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amoxicillin + clavulanate in sepsis, septic shock and bacterial disease, sponsored by University of Tartu. Primary endpoint: Pharmacokinetic parameters of amoxicillin and clavulanic acid. Started Jun 2016; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
sepsisseptic shockbacterial disease
Beyond the preview
Go deeper on 2016-002195-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002195-27.